The remodeling of glycoconjugates in mice

Biochimica et Biophysica Acta - General Subjects

Volumn 1473, Issue 1, 1999, Pages 123-136

  Hennet, Thierry ^a   Ellies, Lesley G ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cre loxP recombination; Gene targeting; Glycosyltransferase; Mouse

Indexed keywords

GLYCOCONJUGATE; GLYCOSIDASE; GLYCOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE METABOLISM; CARBOHYDRATE SYNTHESIS; CELL INTERACTION; GENE DISRUPTION; GENE TARGETING; GLYCOSYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0032739350     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00173-7     Document Type: Review

References (109)

1. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 3:1993;97-130.
2. Hammond C., Helenius A. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7:1995;523-529.
3. Fukuda M. Carbohydrate-dependent cell adhesion. Bioorg. Med. Chem. 3:1995;207-215.
4. Taniguchi N., Yoshimura M., Miyoshi E., Ihara Y., Nishikawa A., Fujii S. Remodeling of cell surface glycoproteins by N-acetylglucosaminyltransferase III gene transfection: modulation of metastatic potentials and down regulation of hepatitis B virus replication. Glycobiology. 6:1996;691-694.
5. Yuan Y.P., Schultz J., Mlodzik M., Bork P. Secreted Fringe-like signaling molecules may be glycosyltransferases. Cell. 88:1997;9-11.
6. Goode S., Wright D., Mahowald A.P. The neurogenic locus brainiac cooperates with the drosophila EGF receptor to establish the ovarian follicle and to determine its dorsal-ventral polarity. Development. 116:1992;177-192.
7. Goode S., Melnick M., Chou T.B., Perrimon N. The neurogenic genes egghead and brainiac define a novel signaling pathway essential for epithelial morphogenesis during Drosophila oogenesis. Development. 122:1996;3863-3879.
8. Herman T., Horvitz H.R. Three proteins involved in Caenorhabditis elegans vulval invagination are similar to components of a glycosylation pathway. Proc. Natl. Acad. Sci. USA. 96:1999;974-979.
9. Varki A., Hooshmand F., Diaz S., Varki N.M., Hedrick S.M. Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-0-acetylesterase. Cell. 65:1991;65-74.
10. Brinster R.L., Palmiter R.D. Introduction of genes into the germ line of animals. Harvey Lect. 80:1984;1-38.
11. Thomas K.R., Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:1987;503-512.
12. Kilby N.J., Snaith M.R., Murray J.A.H. Site-specific recombinases: tools for genome engineering. Trends Genet. 9:1993;413-421.
13. Sauer B., Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA. 85:1988;5166-5170.
14. Hoess R.H., Abremski K. The Cre-lox recombination system. Nucleic Acids Mol. Biol. 4:1990;99-109.
15. Mack A., Sauer B., Abremski K., Hoess R. Stoichiometry of the Cre recombinase bound to the lox recombining site. Nucleic Acids Res. 20:1992;4451-4455.
16. Orban P.C., Chui D., Marth J.D. Tissue- and site-specific DNA recombination in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;6861-6865.
17. Lakso M., Sauer B., Mosinger B. Jr., Lee E.J., Manning R.W., Yu S.-H., Mulder K.L., Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:1992;6232-6236.
18. Marth J.D. Recent advances in gene mutagenesis by site-directed recombination. J. Clin. Invest. 97:1996;1999-2002.
19. Hennet T., Hagen F.K., Tabak L.A., Marth J.D. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyltransferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA. 92:1995;12070-12074.
20. Tarutani M., Itami S., Okabe M., Ikawa M., Tezuka T., Yoshikawa K., Kinoshita T., Takeda J. Tissue-specific knockout of the mouse PIG-A gene reveals important roles for GPI-anchored proteins in skin development. Proc. Natl. Acad. Sci. USA. 94:1997;7400-7405.
21. Rickert R.C., Roes J., Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1997;1317-1318.
22. Stanley P., Raju T.S., Bhaumik M. CHO cells provide access to novel N-glycans and developmentally regulated glycosyltransferases. Glycobiology. 6:1996;695-699.
23. Stanley P., Narasimhan S., Siminovitch L., Schachter H. Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminyltransferase activity. Proc. Natl. Acad. Sci. USA. 72:1975;3323-3327.
24. Armant D.R., Kaplan H.A., Lennarz W.J. N-linked glycoprotein biosynthesis in the developing mouse embryo. Dev. Biol. 113:1986;228-237.
25. Surani M.A. Glycoprotein synthesis and inhibition of glycosylation by tunicamycin in preimplantation mouse embryos compaction and trophoblast adhesion. Cell. 18:1979;217-227.
26. Atienza-Samols S.B., Pine P.R., Sherman M.I. Effects of tunicamycin upon glycoprotein synthesis and development of early mouse embryos. Dev. Biol. 79:1980;19-32.
27. Metzler M., Gertz A., Sarkar M., Schachter H., Schrader J.W., Marth J.D. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J. 13:1994;2056-2065.
28. Ioffe E., Stanley P. Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc. Natl. Acad. Sci. USA. 91:1994;728-732.
29. Campbell R.M., Metzler M., Granovsky M., Dennis J.W., Marth J.D. Complex asparagine-linked oligosaccharides in Mgat1-null embryos. Glycobiology. 5:1995;535-543.
30. Ioffe E., Liu Y., Stanley P. Complex N-glycans in Mgat1 null preimplantation embryos arise from maternal Mgat1 RNA. Glycobiology. 7:1997;913-919.
31. Yokoyama T., Copeland N.G., Jenkins N.A., Montgomery C.A., Elder F.F.B., Overbeek P.A. Reversal of left-right asymmetry: a situs inversus mutation. Science. 260:1993;679-682.
32. Yost H.J. Regulation of vertebrate left-right asymmetries by extracellular matrix. Nature. 357:1992;158-161.
33. Ioffe E., Liu Y., Stanley P. Essential role for complex N-glycans in forming an organized layer of bronchial epithelium. Proc. Natl. Acad. Sci. USA. 93:1996;11041-11046.
34. Chui D., Oh-Eda M., Liao Y.F., Panneerselvam K., Lal A., Marek K.W., Freeze H.H., Moremen K.W., Fukuda M.N., Marth J.D. α-Mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell. 90:1997;157-167.
35. Shaper N.L., Shaper J.H., Meuth J.L., Fox J.L., Chang H., Kirsch I.R., Hollis G.F. Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library. Proc. Natl. Acad. Sci. USA. 83:1986;1573-1577.
36. Asano M., Furukawa K., Kido M., Matsumoto S., Umesaki Y., Kochibe N., Iwakura Y. Growth retardation and early death of β-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J. 16:1997;1850-1857.
37. Lu Q., Hasty P., Shur B.D. Targeted mutation in β1,4-galactosyltransferase leads to pituitary insufficiency and neonatal lethality. Dev. Biol. 181:1997;257-267.
38. Lu Q., Shur B.D. Sperm from β1,4-galactosyltransferase-null mice are refractory to ZP3-induced acrosome reactions and penetrate the zona pellucida poorly. Development. 124:1997;4121-4131.
39. Sato T., Furukawa K., Bakker H., van den Eijnden D.H., Van Die I. Molecular cloning of a human cDNA encoding β-1,4-galactosyltransferase with 37% identity to mammalian UDP-Gal:GlcNAc β-1,4-galactosyltransferase. Proc. Natl. Acad. Sci. USA. 95:1998;472-477.
40. Shaper N.L., Meurer J.A., Joziasse D.H., Chou T.D.D., Smith E.J., Schnaar R.L., Shaper J.H. The chicken genome contains two functional nonallelic β1,4-galactosyltransferase genes. Chromosomal assignment to syntenic regions tracks fate of the two gene lineages in the human genome. J. Biol. Chem. 272:1997;31389-31399.
41. Lo N.W., Shaper J.H., Pevsner J., Shaper N.L. The expanding β4-galactosyltransferase gene family messages from the databanks. Glycobiology. 8:1998;517-526.
42. Almeida R., Amado M., David L., Levery S.B., Holmes E.H., Merkx G., Vankessel A.G., Rygaard E., Hassan H., Bennett E., Clausen H. A family of human β-4-galactosyltransferases - Cloning and expression of two novel UDP-galactose:β-N-acetylglucosamine β1,4-galactosyltransferases, β4Gal-T2 and β4Gal-T3. J. Biol. Chem. 272:1997;31979-31991.
43. Schwientek T., Almeida R., Levery S.B., Holmes E.H., Bennett E., Clausen H. Cloning of a novel member of the UDP-galactose-β-N-acetylglucosamine β-1,4-galactosyltransferase family, β-4Gal-T4, involved in glycosphingolipid biosynthesis. J. Biol. Chem. 273:1998;29331-29340.
44. Luzzatto L., Bessler M., Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell. 88:1997;1-4.
45. Kawagoe K., Kitamura D., Okabe M., Taniuchi I., Ikawa M., Watanabe T., Kinoshita T., Takeda J. Glycosylphosphatidylinositol-anchor-deficient mice implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood. 87:1996;3600-3606.
46. Dunn D.E., Yu J., Nagarajan S., Devetten M., Weichold F.F., Medof M.E., Young N.S., Liu J.M. A knock-out model of paroxysmal nocturnal hemoglobinuria: PIG-A(-) hematopoiesis is reconstituted following intercellular transfer of GPI-anchored proteins. Proc. Natl. Acad. Sci. USA. 93:1996;7938-7943.
47. Fukuda M.N., Masri K.A., Dell A., Luzzatto L., Moremen K.W. Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding α-mannosidase II. Proc. Natl. Acad. Sci. USA. 87:1990;7443-7447.
48. Fukuda M.N. HEMPAS disease genetic defect of glycosylation. Glycobiology. 1:1990;9-15.
49. Gasparini P., Miraglia del Giudice E., Delaunay J., Totaro A., Granatiero M., Melchionda S., Zelante L., Iolascon A. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. Am. J. Hum. Genet. 61:1997;1112-1166.
50. Hakomori S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 50:1981;733-764.
51. Schulte S., Stoffel W. Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning, and expression. Proc. Natl. Acad. Sci. USA. 90:1993;10265-10269.
52. Coetzee T., Fujita N., Dupree J., Shi R., Blight A., Suzuki K., Popko B. Myelination in the absence of galactocerebroside and sulfatide normal structure with abnormal function and regional instability. Cell. 86:1996;209-219.
53. Bosio A., Binczek E., Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl. Acad. Sci. USA. 93:1996;13280-13285.
54. Takamiya K., Yamamoto A., Furukawa K., Yamashiro S., Shin M., Okada M., Fukumoto S., Haraguchi M., Takeda N., Fujimura K., Sakae M., Kishikawa M., Shiku H., Aizawa S. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA. 93:1996;10662-10667.
55. Takamiya K., Yamamoto A., Furukawa K., Zhao J., Fukumoto S., Yamashiro S., Okada M., Haraguchi M., Shin M., Kishikawa M., Shiku H., Aizawa S. Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. Proc. Natl. Acad. Sci. USA. 95:1998;12147-12152.
56. Galili U., Shohet S.B., Kobrin E., Stults C.L., Macher B.A. Man, apes, and old world monkeys differ from other mammals in the expression of α-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263:1988;17755-17762.
57. Larsen R.D., Rivera-Marrero C.A., Ernst L.K., Cummings R.D., Lowe J.B. Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal(1,4)-D-GlcNAc α(1,3)-galactosyltransferase cDNA. J. Biol. Chem. 265:1990;7055-7061.
58. Joziasse D.H., Shaper J.H., Jabs E.W., Shaper N.L. Characterization of an α1-3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. J. Biol. Chem. 266:1991;6991-6998.
59. Thall A.D., Maly P., Lowe J.B. Oocyte Gal α1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 270:1995;21437-21440.
60. Tearle R.G., Tange M.J., Zannettino Z.L., Katerelos M., Shinkel T.A., Van Denderen B.J., Lonie A.J., Lyons I., Nottle M.B., Cox T., Becker C., Peura A.M., Wigley P.L., Crawford R.J., Robins A.J., Pearse M.J., d'Apice A.J. The α-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation. Transplantation. 61:1996;13-19.
61. Smith D.F., Larsen R.D., Mattox S., Lowe J.B., Cummings R.D. Transfer and expression of the murine UDP-Gal:β-Gal-α1,3-galactosyltransferase gene in transfected Chinese hamster ovary cells. Competition reactions between the α1,3-galactosyltransferase and the endogenous α2,3-sialyltransferase. J. Biol. Chem. 265:1990;6225-6234.
62. Abraham E.C., Swamy M.S., Perry R.E. Nonenzymatic glycosylation (glycation) of lens crystallins in diabetes and aging. Prog. Clin. Biol. Res. 304:1989;123-139.
63. Shinkel T.A., Chen C.G., Salvaris E., Henion T.R., Barlow H., Galili U., Pearse M.J., d'Apice A.J. Changes in cell surface glycosylation in α1,3-galactosyltransferase knockout and α1,2-fucosyltransferase transgenic mice. Transplantation. 64:1997;197-204.
64. Koike C., Katayama A., Kadomatsu K., Hiraiwa N., Hayashi S., Kobayashi T., Hayash S., Yokoyama I., Takagi H. Reduction of α-Gal epitopes in transgenic pig by introduction of human α1-2 fucosyltransferase. Transpl. Proc. 29:1997;894-894.
65. Chen C.G., Salvaris E.J., Romanella M., Aminian A., Katerelos M., Fisicaro N., d'Apice A.J., Pearse M.J. Transgenic expression of human α1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation. 65:1998;832-837.
66. Bhaumik M., Seldin M.F., Stanley P. Cloning and chromosomal mapping of the mouse Mgat3 gene encoding N-acetylglucosaminyltransferase III. Gene. 164:1995;295-300.
67. Priatel J.J., Sarkar M., Schachter H., Marth J.D. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. Glycobiology. 7:1997;45-56.
68. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc. Natl. Acad. Sci. USA. 92:1995;8754-8758.
69. Ihara Y., Sakamoto Y., Mihara M., Shimizu K., Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor. J. Biol. Chem. 272:1997;9629-9634.
70. Rebbaa A., Yamamoto H., Saito T., Meuillet E., Kim P., Kersey D.S., Bremer E.G., Taniguchi N., Moskal J.R. Gene transfection-mediated overexpression of β1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function. J. Biol. Chem. 272:1997;9275-9279.
71. Bhaumik M., Harris T., Sundaram S., Johnson L., Guttenplan J., Rogler C., Stanley P. Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: Evidence for a glycoprotein factor that facilitates hepatic tumor progression. Cancer Res. 58:1998;2881-2887.
72. Kansas G.S. Selectins and their ligands: current concepts and controversies. Blood. 88:1996;3259-3287.
73. McEver R.P., Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J. Clin. Invest. 100:1997;S97-S103.
74. Etzioni A., Frydman M., Pollack S., Avidor I., Phillips M.L., Paulson J.C., Gershoni-Baruch R. Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N. Engl. J. Med. 327:1992;1789-1792.
75. von Andrian U.H., Berger E.M., Ramezani L., Chambers J.D., Ochs H.D., Harlan J.M., Paulson J.C., Etzioni A., Arfors K.-E. In vivo behavior of neutrophils from two patients with distinct inherited leukocyte adhesion deficiency syndromes. J. Clin. Invest. 91:1993;2893-2897.
76. Maly P., Thall A.D., Petryniak B., Rogers G.E., Smith P.L., Marks R.M., Kelly R.J., Gersten K.M., Cheng G.Y., Saunders T.L., Camper S.A., Camphausen R.T., Sullivan F.X., Isogai Y., Hindsgaul O., Von Andrian U.H., Lowe J.B. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell. 86:1996;643-653.
77. Bierhuizen M.F., Fukuda M. Expression cloning of a cDNA encoding UDP-GlcNAc:Galβ1-3-GalNAc-R (GlcNAc to GalNAc) β1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc. Natl. Acad. Sci. USA. 89:1992;9326-9330.
78. Ellies L.G., Tsuboi S., Petryniak B., Lowe J.B., Fukuda M., Marth J.D. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity. 9:1998;881-890.
79. Yeh J.C., Ong E., Fukuda M. Molecular cloning and expression of a novel β-1,6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches. J. Biol. Chem. 274:1999;3215-3221.
80. Hennet T., Chui D., Paulson J.C., Marth J.D. Immune regulation by the ST6Gal sialyltransferase. Proc. Natl. Acad. Sci. USA. 95:1998;4504-4509.
81. Wang X.C., Smith T.J., Lau J.T.Y. Transcriptional regulation of the liver β-galactoside α2,6-sialyltransferase by glucocorticoids. J. Biol. Chem. 265:1990;17849-17853.
82. Svensson E.C., Conley P.B., Paulson J.C. Regulated expression of α2,6-sialyltransferase by the liver-enriched transcription factors HNF-1, DBP, and LAP. J. Biol. Chem. 267:1992;3466-3472.
83. Hu Y.P., Dalziel M., Lau J.T. Murine hepatic β-galactoside α-2,6-sialyltransferase gene expression involves usage of a novel upstream exon region. Glycoconjug. J. 14:1997;407-411.
84. Lo N.W., Lau J.T. Transcription of the β-galactoside α-2,6-sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter. Glycobiology. 6:1996;271-279.
85. Hanasaki K., Varki A., Stamenkovic I., Bevilacqua M.P. Cytokine-induced β-galactoside α-2,6-sialyltransferase in human endothelial cells mediates α2,6-sialylation of adhesion molecules and CD22 ligands. J. Biol. Chem. 269:1994;10637-10645.
86. Hanks M., Wurst W., Anson-Cartwright L., Auerbach A.B., Joyner A.L. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science. 269:1995;679-682.
87. R. Oriol, in: J.-P. Cartron, P. Rouger (Eds.), Molecular Basis of Human Blood Group Antigens, Plenum Press, New York, 1995, pp. 37-73.
88. Mollicone R., Reguigne I., Kelly R.J., Fletcher A., Watt J., Chatfield S., Aziz A., Cameron H.S., Weston B.W., Lowe J.B., Oriol R. Molecular basis for Lewis α(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative indonesian pedigrees. J. Biol. Chem. 269:1994;20987-20994.
89. Mollicone R., Reguigne I., Fletcher A., Aziz A., Rustam M., Weston B.W., Kelly R.J., Lowe J.B., Oriol R. Molecular basis for plasma α(1,3)-fucosyltransferase gene deficiency (FUT6). J. Biol. Chem. 269:1994;12662-12671.
90. Burt A., Bell G. Mammalian chiasma frequencies as a test of two theories of recombination. Nature. 326:1987;803-805.
91. Gagneux P., Varki A. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology. 9:1999;747-755.
92. Muchmore E.A., Diaz S., Varki A. A structural difference between the cell surfaces of humans and the great apes. Am. J. Phys. Anthropol. 107:1998;187-198.
93. Takeuchi Y., Porter C.D., Strahan K.M., Preece A.F., Gustafsson K., Cosset F.L., Weiss R.A., Collins M.K. Sensitization of cells and retroviruses to human serum by (α1-3) galactosyltransferase. Nature. 379:1996;85-88.
94. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., Wiley D.C. Structure of the influenza virus haemagglutinin complexed with its receptor sialic acid. Nature. 333:1988;426-431.
95. Barlow C., Schroeder M., Lekstrom-Himes J., Kylefjord H., Deng C.X., Wynshaw-Boris A., Spiegelman B.M., Xanthopoulos K.G. Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments. Nucleic Acids Res. 25:1997;2543-2545.
96. Agah R., Frenkel P.A., French B.A., Michael L.H., Overbeek P.A., Schneider M.D. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100:1997;169-179.
97. Wagner K.U., Wall R.J., St-Onge L., Gruss P., Wynshaw-Boris A., Garrett L., Li M., Furth P.A., Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25:1997;4323-4330.
98. Nelson R.D., Stricklett P., Gustafson C., Stevens A., Ausiello D., Brown D., Kohan D.E. Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive system of transgenic mice. Am. J. Physiol. 275:1998;216-226.
99. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA. 93:1996;5860-5865.
100. O'Gorman S., Dagenais N.A., Qian M., Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 94:1997;14602-14607.
101. Lewandoski M., Wassarman K.M., Martin G.R. Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line. Curr. Biol. 7:1997;148-151.
102. Kuhn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 269:1995;1427-1429.
103. St-Onge L., Furth P.A., Gruss P. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res. 24:1996;3875-3877.
104. Lallemand Y., Luria V., Haffner-Krausz R., Lonai P. Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res. 7:1998;105-112.
105. Terry R.W., Kwee L., Baldwin H.S., Labow M.A. Cre-mediated generation of a VCAM-1 null allele in transgenic mice. Transgenic Res. 6:1997;349-356.
106. Betz U.A.K., Vosshenrich C.A.J., Rajewsky K., Muller W. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination. Curr. Biol. 6:1996;1307-1316.
107. M. Granovsky, J. Fata, R. Khokha, J.W. Dennis, N-acetylglucosaminyltransferase V null mice show hypersensitivity to T cell mitogens and intestinal hyperplasia, Glycobiology 8 (1998) abstract.
108. N. Chen, P. Soloway, J.T. Lau, Functional analysis of ST3Gal-2 by targeted mutagenesis, Glycobiology 8 (1998) abstract.
109. F.I. Smith, O. Koul, T. Baboval, J.B. Lowe, J. Crandall, Comparison of SSEA-1 antigen expression and fucosyltransferase properties in the postnatal cerebellum of normal and mFucT-IV knockout mice, Glycobiology 8 (1998) abstract.